Skip to main content

Proceeding contribution from Earl Howe (Conservative) in the House of Lords on Tuesday, 15 January 2008. It occurred during Debate on bill on Human Fertilisation and Embryology Bill [HL].


Human Fertilisation and Embryology Bill [HL]

I agree with noble Lords who have spoken. The noble Lord, Lord Patel, has made a powerful case and I support him. I do, however, have a technical question about the approvals process. If the amendment were accepted, will the Minister confirm that it would cover research only? If there were any question of the technique being applied to treat an individual patient, which regulatory body would license it? Would it be the HFEA, or would it be the MHRA, bearing in mind that we would suppose by that stage that the technique had been developed to a sufficient stage to enable it to be applied in the field? In other words, would regulations passed under the Bill as amended enable patients to be treated?


Secondary information

Type
Proceeding contribution
Reference
697 c1200 
Session
2007-08
Chamber / Committee
House of Lords chamber
Subjects
Animals Congenital abnormalities Fertility Licensing Human embryo experiments Diseases Genetics Human Fertilisation and Embryology Authority Ethics IVF Research Stem cells Human-animal hybrid embryos
Legislation
Human Fertilisation and Embryology Bill (HL) 2007-08
Link
View this Proceeding contribution on www.publications.parliament.uk